Rosh-Ha′ayin, Israel

Itzhak Benwich


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Itzhak Benwich: Innovator in Cancer Research

Introduction

Itzhak Benwich is a prominent inventor based in Rosh-Ha′ayin, Israel. He has made significant contributions to the field of cancer research, particularly in understanding the role of microRNAs in prostate and lung cancer. His innovative work has the potential to impact diagnosis and treatment options for these medical conditions.

Latest Patents

Itzhak Benwich holds a patent titled "MicroRNAs and uses thereof." This patent describes polynucleotides associated with prostate and lung cancer. The polynucleotides include miRNAs and miRNA precursors. The patent also discloses related methods and compositions that can be utilized for diagnosis, prognosis, and treatment of these cancers. Furthermore, it outlines methods for identifying modulators of prostate and lung cancer.

Career Highlights

Benwich has dedicated his career to advancing cancer research. His work at Rosetta Genomics Ltd. has positioned him as a key figure in the development of innovative diagnostic and therapeutic strategies. His research focuses on the molecular mechanisms underlying cancer, contributing to a better understanding of disease progression and treatment.

Collaborations

Itzhak Benwich collaborates with notable colleagues, including Amir Avniel and Yael Karov. These partnerships enhance the research efforts at Rosetta Genomics Ltd. and foster a collaborative environment for innovation in cancer research.

Conclusion

Itzhak Benwich is a distinguished inventor whose work in microRNA research holds promise for improving cancer diagnosis and treatment. His contributions to the field are invaluable, and his ongoing research continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…